KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Rad Laboratories (BIO) Divestments (2020 - 2023)

Bio-Rad Laboratories (BIO) has disclosed Divestments for 3 consecutive years, with $2.5 million as the latest value for Q4 2023.

  • On a quarterly basis, Divestments rose 6150.0% to $2.5 million in Q4 2023 year-over-year; TTM through Dec 2023 was $2.5 million, a 6250.0% increase, with the full-year FY2023 number at $2.5 million, up 78.57% from a year prior.
  • Divestments was $2.5 million for Q4 2023 at Bio-Rad Laboratories, up from $40000.0 in the prior quarter.
  • In the past five years, Divestments ranged from a high of $12.2 million in Q2 2020 to a low of $40000.0 in Q4 2022.
  • A 3-year average of $4.9 million and a median of $2.5 million in 2023 define the central range for Divestments.
  • Biggest YoY gain for Divestments was 6150.0% in 2023; the steepest drop was 6150.0% in 2023.
  • Bio-Rad Laboratories' Divestments stood at $12.2 million in 2020, then tumbled by 99.67% to $40000.0 in 2022, then soared by 6150.0% to $2.5 million in 2023.
  • Per Business Quant, the three most recent readings for BIO's Divestments are $2.5 million (Q4 2023), $40000.0 (Q4 2022), and $12.2 million (Q2 2020).